- Home
- BIOA vs PTMN Comparison
BIOA vs PTMN Comparison
Compare BIOA & PTMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIOA
- PTMN
- Stock Information
- Founded
- BIOA 2015
- PTMN 2006
- Country
- BIOA United States
- PTMN United States
- Employees
- BIOA N/A
- PTMN N/A
- Industry
- BIOA Biotechnology: Pharmaceutical Preparations
- PTMN Finance: Consumer Services
- Sector
- BIOA Health Care
- PTMN Finance
- Exchange
- BIOA Nasdaq
- PTMN Nasdaq
- Market Cap
- BIOA 139.1M
- PTMN 142.6M
- IPO Year
- BIOA 2024
- PTMN N/A
- Fundamental
- Price
- BIOA $3.82
- PTMN $14.37
- Analyst Decision
- BIOA Hold
- PTMN Hold
- Analyst Count
- BIOA 4
- PTMN 1
- Target Price
- BIOA $5.67
- PTMN $16.00
- AVG Volume (30 Days)
- BIOA 156.6K
- PTMN 52.0K
- Earning Date
- BIOA 05-15-2025
- PTMN 03-13-2025
- Dividend Yield
- BIOA N/A
- PTMN 15.04%
- EPS Growth
- BIOA N/A
- PTMN N/A
- EPS
- BIOA N/A
- PTMN N/A
- Revenue
- BIOA N/A
- PTMN $62,432,000.00
- Revenue This Year
- BIOA N/A
- PTMN $6.34
- Revenue Next Year
- BIOA N/A
- PTMN N/A
- P/E Ratio
- BIOA N/A
- PTMN N/A
- Revenue Growth
- BIOA N/A
- PTMN N/A
- 52 Week Low
- BIOA $3.80
- PTMN $14.30
- 52 Week High
- BIOA $26.62
- PTMN $20.84
- Technical
- Relative Strength Index (RSI)
- BIOA N/A
- PTMN 18.92
- Support Level
- BIOA N/A
- PTMN $14.30
- Resistance Level
- BIOA N/A
- PTMN $15.69
- Average True Range (ATR)
- BIOA 0.00
- PTMN 0.43
- MACD
- BIOA 0.00
- PTMN -0.17
- Stochastic Oscillator
- BIOA 0.00
- PTMN 2.35
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
About PTMN Portman Ridge Finance Corporation
Portman Ridge Finance Corp Inc is a non-diversified closed-end investment company. The company originates, structures, and invests in secured term loans, bonds or notes, and mezzanine debt primarily in privately-held middle market companies but may also invest in other investments such as loans to publicly traded companies, high-yield bonds, and distressed debt securities. The company's investment objective in the Debt securities portfolio is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt, and selected equity investments in privately-held middle market companies.